Funds advised by Apax Partners have agreed to acquire Qualitest and Vintage Pharmaceuticals, a leading distributor and manufacturer of generic pharmaceuticals based in Huntsville, Alabama, USA.
Founded in 1983 by William Propst, Qualitest and Vintage Pharmaceuticals was established to provide quality generic medicines at affordable prices. The company now produces tablets, capsules, liquids, suspensions, suppositories, creams and ointments across a portfolio of over 160 products. The business has grown significantly over the past 24 years and is currently ranked among the top 10 suppliers of generic pharmaceuticals based on the total number of prescriptions filled.
Apax Partners has invested over $2.8 billion in the health care sector since 1989 and has a team of 13 investment professionals across its global platform. The team has spent the past two years specifically involved in the generic pharmaceutical industry, working with a range of leading industry executives and operators.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze